Document is current
Any future updates will be listed below
-
Authors
Zhu, Junjie
Qin, Fu-Ying
Lei, Saifei
Gu, Ruizhi
Qi, Qian
Lu, Jie
Anderson, Karl E. https://orcid.org/0000-0002-6499-8573
Wipf, Peter https://orcid.org/0000-0001-7693-5863
Ma, Xiaochao https://orcid.org/0000-0003-2049-7467
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R01DK126875)
- License Information
-
More Information
Article History
Received: 8 February 2024
Accepted: 21 November 2024
First Online: 4 December 2024
Competing interests
: X.M., J.Z., and J.L. are inventors on a patent (WO2020236901) and hold equity in Portal Therapeutics, Inc. K.E.A. reports receiving consulting fees, advisory board fees and grants to the university from Alnylam Pharmaceuticals, Recordati Rare Diseases, Mitsubishi Tanabe Pharma America, Disc Medicine and Portal Therapeutics. The remaining authors declare no competing interests.
